Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299)
Clinical trial NCT00203372 · COMPLETED
Trial details
- NCT number
- NCT00203372
- Sponsor
- Translational Oncology Research International
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2012-06-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.